| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-07 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.22 | 5e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |